Contrarian Corpus
activist conference presentation initial thesis
2017-05-08 · 63 pages

Core Laboratories CLB

Core Lab trades at 35x 2018e P/E — double its oilfield-service peers — on a false secular-growth narrative; mid-cycle earnings imply $62 fair value and ~45% downside.

N 5 Narrative
V 3 Visual
C 3 Craft
Original source ↗

Thesis

Core Laboratories trades at $113 — 35x 2018e and 27x 2019e consensus earnings, roughly twice its oilfield-service peers — on the strength of a false narrative that it is a secular growth business with industry-leading ROIC. In reality, Core is a cyclical oilfield-service company whose 70-80% non-US revenue ties it to international and deepwater capex, not the US shale story management now trumpets. CEO David Demshur is a narrative chameleon, pivoting the annual report from international crude to shale to deepwater to LNG to neural networks, and has called a V-shaped recovery at least seven times since 2015. Meanwhile Core repurchased stock at $144 using debt, issued equity at $118 to avoid tripping covenants, and now funds its dividend from new stock sales. Greenlight values Core at $62 on mid-cycle EPS of $3.52 — roughly 45% downside.

SCQA

Situation

Core Laboratories is a $5bn oilfield-service company that analyzes reservoirs and sells well-completion tools; the asset-light Reservoir Description lab segment generates 71% of revenue and 89% of EBIT.

Complication

The market prices Core at more than twice its peers' multiple on a false narrative of secular growth and industry-leading ROIC, when it is in fact a cyclical offshore-capex proxy whose CEO reinvents the pitch annually.

Resolution

Strip the hype and value Core on trailing 10-year mid-cycle EPS of $3.52 at an S&P 500 multiple of 17.7x, recognizing the chameleon narrative and the buy-high / sell-low capital allocation.

Reward

Fair value of $62.30 implies roughly 45% downside from $113.43; earnings should disappoint over the next several years as offshore and international capex remain depressed.

The three reasons

  1. 1

    Core trades at 35x 2018e P/E — twice the oilfield-service peer average

  2. 2

    Management rewrites the 'laser focus' narrative yearly: shale, deepwater, LNG, now AI

  3. 3

    Dividend exceeds earnings — Core funds the shortfall by issuing fresh stock

KPIs cited

2018e P/E
CLB 35.0x vs oilfield-service peer average 19.8x (Schlumberger, Baker Hughes, Halliburton, Oceaneering, NOV, Oil States) — roughly 2x
Prior-peak P/E
CLB 19.4x vs peer average 9.0x — more than twice peers
2019e EV/EBIT
CLB 21.5x vs peer average 13.5x
Segment mix 2016
Reservoir Description = 71% of revenue / 89% of EBIT; Production Enhancement = 29% / 11%
Non-US revenue origination
70-80% of revenue originates from reservoirs outside the US (GAAP misreports because samples analyzed in Houston count as US)
2019e EPS — Greenlight vs consensus
Greenlight $3.09 vs Street $4.23 (~27% below)
Mid-cycle EPS (2007-2016 trailing 10yr average)
$3.52
Fair value
$62.30 = mid-cycle EPS $3.52 × S&P 500 17.7x; 45% below $113.43 spot
Capital allocation
~$230M debt-funded buybacks 2012-2015 at avg $144/share; $200M equity issuance in 2016 at $118/share to repay
Dividend coverage
Adjusted EPS has run below quarterly dividend for 5 consecutive quarters (Q1'16–Q1'17); shortfall funded by stock issuance

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns.

Notable slides (6)

Notes

Classic Einhorn Sohn short pitch: title-quote-cartoon template, extensive use of CEO's own serial pivots (annual reports 2011→2015, V-recovery calls since 2015, peak-oil claim) as contradiction evidence. Disclaimer (p.2) notes 'existing position' but no stake size disclosed. Valuation is mid-cycle-EPS × market multiple rather than sum-of-parts; no explicit DCF or SOTP. Closing slides (61-63) imply — without using the word — that dividend funded by equity issuance is a Ponzi. New Yorker cartoons on most slides are a signature rhetorical device. Short-side call with no activist demand.